SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-21-000042
Filing Date
2021-08-09
Accepted
2021-08-09 16:58:55
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20210630x10q.htm   iXBRL 10-Q 2961238
2 EX-31.1 plse-20210630xex31_1.htm EX-31.1 23815
3 EX-31.2 plse-20210630xex31_2.htm EX-31.2 23991
4 EX-32.1 plse-20210630xex32_1.htm EX-32.1 21501
  Complete submission text file 0001625101-21-000042.txt   8753193

Data Files

Seq Description Document Type Size
5 EX-101.SCH plse-20210630.xsd EX-101.SCH 42572
6 EX-101.CAL plse-20210630_cal.xml EX-101.CAL 54291
7 EX-101.DEF plse-20210630_def.xml EX-101.DEF 145885
8 EX-101.LAB plse-20210630_lab.xml EX-101.LAB 345040
9 EX-101.PRE plse-20210630_pre.xml EX-101.PRE 322408
10 EXTRACTED XBRL INSTANCE DOCUMENT plse-20210630x10q_htm.xml XML 1579569
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 211157288
SIC: 3841 Surgical & Medical Instruments & Apparatus